A closed-circuit neonatal xenon delivery system: A technical and practical neuroprotection feasibility study in newborn pigs

Anesthesia and Analgesia

Volumn 109, Issue 2, 2009, Pages 451-460

  Chakkarapani, Ela ^a   Thoresen, Marianne ^a   Hobbs, Catherine E ^a   Aquilina, Kristian ^a   Liu, Xun ^a   Dingley, John ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; XENON; INHALATION ANESTHETIC AGENT; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; BRAIN ISCHEMIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENDOTRACHEAL TUBE; EXPERIMENTAL PIG; GAS EXCHANGE; HEART RATE; INDUCED HYPOTHERMIA; INHALATION ANESTHESIA; NEUROPROTECTION; NEWBORN; NONHUMAN; OXYGEN BREATHING; OXYGEN CONCENTRATION; OXYGEN SATURATION; PRIORITY JOURNAL; STEADY STATE; VENTILATOR; WEANING; ANIMAL; ANOXIA; BLOOD PRESSURE; COST BENEFIT ANALYSIS; CRYOANESTHESIA; ECONOMICS; FEASIBILITY STUDY; METHODOLOGY; NEUROLOGIC DISEASE; PHYSIOLOGY; STATISTICAL MODEL; SWINE;

ANESTHESIA, CLOSED-CIRCUIT; ANESTHETICS, INHALATION; ANIMALS; ANIMALS, NEWBORN; ANOXIA; BLOOD PRESSURE; COST-BENEFIT ANALYSIS; FEASIBILITY STUDIES; HYPOTHERMIA, INDUCED; MODELS, STATISTICAL; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; OXYGEN; RESPIRATION, ARTIFICIAL; SWINE; XENON;

EID: 67849090637     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181aa9550     Document Type: Article

References (45)

1. Petzelt C, Blom P, Schmehl W, Muller J, Kox WJ. Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Life Sci 2003;72:1909-1918
2. Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br J Anaesth 2002;89:739-746 (Pubitemid 35277224)
3. Ma D, Yang H, Lynch J, Franks NP, Maze M, Grocott HP. Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 2003;98: 690-698
4. Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, Mehmet H, Edwards AD, Franks NP, Maze M. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005;58:182-193
5. Martin JL, Ma D, Hossain M, Xu J, Sanders RD, Franks NP, Maze M. Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat. Br J Anaesth 2007;98:236-240
6. Dingley J, Tooley J, Porter H, Thoresen M. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 2006;37:501-506
7. Hobbs C, Thoresen M, Tucker A, Aquilina K, Chakkarapani E, Dingley J. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke 2008;39:1307-1313
8. Ma D, Hossain M, Pettet GK, Luo Y, Lim T, Akimov S, Sanders RD, Franks NP, Maze M. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab 2006;26:199-208
9. Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR. How does xenon produce anaesthesia? Nature 1998;396:324
10. Natale G, Cattano D, Abramo A, Forfori F, Fulceri F, Fornai F, Paparelli A, Giunta F. Morphological evidence that xenon neuroprotects against N-methyl-dl-aspartic acid-induced damage in the rat arcuate nucleus: a time-dependent study. Ann N Y Acad Sci 2006;1074:650-658
11. Dinse A, Fohr KJ, Georgieff M, Beyer C, Bulling A, Weigt HU. Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones. Br J Anaesth 2005;94:479-485
12. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-pore-domain K- channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004;65:443-452
13. Finer NN, Robertson CM, Richards RT, Pinnell LE, Peters KL. Hypoxic-ischemic encephalopathy in term neonates: perinatal factors and outcome. J Pediatr 1981;98:112-117
14. Johnston MV. Excitotoxicity in neonatal hypoxia. Ment Retard Dev Disabil Res Rev 2001;7:229-234
15. Bona E, Hagberg H, Loberg EM, Bagenholm R, Thoresen M. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome. Pediatr Res 1998;43:738-745
16. Ginsberg MD, Sternau LL, Globus MY, Dietrich WD, Busto R. Therapeutic modulation of brain temperature: relevance to ischemic brain injury. Cerebrovasc Brain Metab Rev 1992;4: 189-225
17. Tooley JR, Satas S, Porter H, Silver IA, Thoresen M. Head cooling with mild systemic hypothermia in anesthetized piglets is neuroprotective. Ann Neurol 2003;53:65-72
18. Gunn AJ, Thoresen M. Hypothermic neuroprotection. NeuroRx 2006;3:154-169
19. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005;365:663-670
20. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005;353:1574-1584
21. Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA, Horgan MJ, Languani S, Bhatia JJ, Givelichian LM, Sankaran K, Yager JY. Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol 2005;32: 11-17 (Pubitemid 40018099)
22. Rossaint R, Reyle-Hahn M, Schulte Am Esch J, Scholz J, Scherpereel P, Vallet B, Giunta F, Del Turco M, Erdmann W, Tenbrinck R, Hammerle AF, Nagele P; Xenon Study Group. Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003;98:6-13
23. Dingley J, King R, Hughes L, Terblanche C, Mahon S, Hepp M, Youhana A, Watkins A. Exploration of xenon as a potential cardiostable sedative: a comparison with propofol after cardiac surgery. Anaesthesia 2001;56:829-835
24. Lane GA, Nahrwold ML, Tait AR, Taylor-Busch M, Cohen PJ, Beaudoin AR. Anesthetics as teratogens: nitrous oxide is fetotoxic, xenon is not. Science 1980;210:899-901
25. Burov NE, Arzamastsev EV, Kornienko L, Kudimova LA. [Investigation of the teratogenic and embryotoxic action of xenon]. Anesteziol Reanimatol 2002:69-70
26. Jayasinghe D, Gill AB, Levene MI. CBF reactivity in hypotensive and normotensive preterm infants. Pediatr Res 2003;54:848-853
27. Wilhelm S, Ma D, Maze M, Franks NP. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 2002;96:1485-1491
28. Tymianski M, Sattler R, Zabramski JM, Spetzler RF. Characterization of neuroprotection from excitotoxicity by moderate and profound hypothermia in cultured cortical neurons unmasks a temperature-insensitive component of glutamate neurotoxicity. J Cereb Blood Flow Metab 1998;18:848-867
29. Busto R, Globus MY, Dietrich WD, Martinez E, Valdes I, Ginsberg MD. Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain. Stroke 1989;20:904-910
30. Lynch C III, Baum J, Tenbrinck R. Xenon anesthesia. Anesthesiology 2000;92:865-868
31. Nunn JF, Halsey MJ. Xenon in anaesthesia. Lancet 1990;336: 112-113
32. Goto T, Suwa K, Uezono S, Ichinose F, Uchiyama M, Morita S. The blood-gas partition coefficient of xenon may be lower than generally accepted. Br J Anaesth 1998;80:255-256
33. Luttropp HH, Thomasson R, Dahm S, Persson J, Werner O. Clinical experience with minimal flow xenon anesthesia. Acta Anaesthesiol Scand 1994;38:121-125
34. Farrari A, Erdmann W, Del Tacca M, Formichi B, Volta C, Ferrari E, Bissolotti G, Giunta F. Xenon anesthesia: clinical results and recycling of gas. Appl Cardiopulm Pathophysiol 1998;7:153-155
35. Baum JA. New and alternative delivery concepts and techniques. Best Pract Res Clin Anaesthesiol 2005;19:415-428
36. Burov NE, Molchanov IV, Nikolaev LL, Rashchupkin AB. [The method of low-flow xenon anesthesia]. Anesteziol Reanimatol 2003:31-34
37. Dingley J, Findlay GP, Foex BA, Mecklenburgh J, Esmail M, Little RA. A closed xenon anesthesia delivery system. Anesthesiology 2001;94:173-176
38. Lockwood G, White DC. Measuring the costs of inhaled anaesthetics. Br J Anaesth 2001;87:559-563
39. ICRP. ICRP (International Commission on Radiological Protection) 2002. Basic anatomical and physiological data for use in radiological protection: reference values publication 89. Oxford: Pergamon, 2002
40. Hellstrom-Westas L, Rosen I. Continuous brain function monitoring: state of the art in clinical practice. Semin Fetal Neonatal Med 2006;11:503-511
41. Thoresen M, Haaland K, Loberg EM, Whitelaw A, Apricena F, Hanko E, Steen PA. A piglet survival model of posthypoxic encephalopathy. Pediatr Res 1996;40:738-748
42. Nathan N, Sperandio M, Erdmann W, Westerkamp B, Van Dijk G, Scherpereel P, Feiss P. [PhysioFlex: a target-controlled selfregulating closed-circuit inhalation anesthesia regulator]. Ann Fr Anesth Reanim 1997;16:534-540
43. Thoresen M, Whitelaw A. Cardiovascular changes during mild therapeutic hypothermia and rewarming in infants with hypoxic-ischemic encephalopathy. Pediatrics 2000;106:92-99
44. Weiss M, Gerber AC. Cuffed tracheal tubes in children-things have changed. Pediatr Anesth 2008;16:1005-1007
45. Ishiguro Y, Saito H, Nakata Y, Goto T, Terui K, Niimi Y, Morita S. Effect of xenon on endotracheal tube cuff. J Clin Anesth 2000;12:371-373